Hypofractionated Regional Nodal Irradiation in Breast Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 13, 2018

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Breast Cancer
Interventions
RADIATION

hypofractionated radiation

All patients will receive a dose of 42.56 Gy in 16 daily fractions to the whole breast or chest wall and regional lymph nodes. A boost dose of 10 or 12.5 Gy in 4 or 5 daily fractions of 2.5 Gy, respectively, will be administered to either the lumpectomy cavity or mastectomy scar, as appropriate.

Trial Locations (3)

48073

Corewell Health William Beaumont University Hospital, Royal Oak

48085

Corewell Health Beaumont Troy Hospital, Troy

48124

Corewell Health Dearborn Hospital, Dearborn

All Listed Sponsors
lead

William Beaumont Hospitals

OTHER

NCT06443359 - Hypofractionated Regional Nodal Irradiation in Breast Cancer | Biotech Hunter | Biotech Hunter